Erythema dyschromicum perstans
Erythema dyschromicum perstans (EDP), also known as ashy dermatosis or dermatosis cenicienta, is a chronic, slowly progressive acquired pigment disorder. It produces slate-gray, ash-gray, or blue-gray macules and patches, usually distributed symmetrically on the trunk, neck, and arms, and only rarely on the face, palms, soles, or mucous membranes.
Early on, the edge of an EDP patch may show a slightly raised red border, a sign of active low-grade inflammation. This border is usually short-lived and fades, leaving a gray patch that can persist for years. Under the microscope, EDP is a form of interface dermatitis at the junction of the epidermis and dermis: it damages the basement membrane and causes heavy pigment incontinence into the upper dermis.
At Haute-Derma, our EDP protocol follows three steps: control the chronic interface inflammation, rebuild the basement membrane, and clear melanophages with low-fluence 1064 nm picosecond laser. This fades the ashy pigment, restores a natural skin tone, and gives the best possible cosmetic result.
Pathogenesis and Cellular Mechanisms of Erythema Dyschromicum Perstans
EDP is driven by a complex cell-mediated immune reaction aimed directly at the basement membrane zone:
- Cytotoxic (CD8+) T-cell interface reaction: CD8+ T cells, activated by risk factors (chronic infection, chemicals, environmental exposures, or genetic susceptibility such as HLA-DR4), attack basal keratinocytes. This causes vacuolar alteration of the basal layer and triggers apoptosis.
- Pigment incontinence and melanophage buildup: Destruction of basal cells breaks the basement membrane, and melanosomes made by melanocytes fall into the upper dermis. There, macrophages engulf the melanin and become melanophages. Because melanophages sit in the dermis and persist for a long time, the way the skin reflects light produces a lasting ash-gray or blue-gray tone.
- Chronic micro-inflammation and dermal vascular changes: A persistent infiltrate of T cells and plasma cells around the superficial dermal vessels keeps a smoldering inflammation going and reduces the lymphatic system's ability to clear the damage.
Differential Diagnosis of Patchy Dermal Hyperpigmentation
| Erythema dyschromicum perstans (EDP) | Lichen planus pigmentosus (LPP) | Fixed drug eruption (FDE) |
|---|---|---|
| Ash-gray, slate-gray, blue-gray | Gray-black, dark gray-brown | Dusky red, turning dark gray-brown |
| May have a slightly raised red border early on | No red border | Often has acute blisters or red papules |
| Trunk, neck, limbs (rarely the face) | Sun-exposed areas (face, neck) and skin folds | Same fixed sites each time (lips, genitals, limbs) |
| Little or no itch | Mild to moderate itch | Burning or stinging pain in the acute phase |
| Uneven slate-gray to blue-gray dots/globules | Gray-black pseudoreticular pattern around follicles | Dark gray-brown patch with fine dilated vessels |
Examination, Dermoscopy, and Medical Screening at Haute-Derma
- History and trigger screening: We ask about exposure to industrial chemicals and nitrates, specific foods or medications (ethambutol, penicillin), and chronic infections (the parasite Trichuris trichiura, hepatitis C, HIV).
- Detailed dermoscopy: Dermoscopic features of EDP: Sparse slate-gray or blue-gray dots and globules, sometimes forming a pseudoreticular pattern. In the active phase, a network of dilated red microvessels can be seen at the lesion edge.
- Pigment Depth Assessment and Biopsy (When Needed)
- A Wood's lamp helps gauge pigment depth (dermal pigment shows no increase in contrast under Wood's light).
- If the lesion is hard to distinguish from LPP or FDE, a small skin biopsy is taken to confirm a vacuolar interface dermatitis.
Treatment Protocol for Erythema Dyschromicum Perstans at Haute-Derma
- Switching Off Interface Inflammation and Protecting the Basement Membrane
- Topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) twice daily to stop the T-cell attack on the basal layer without causing skin thinning.
- In very active EDP, a short course of oral clofazimine or dapsone may be added to modulate the immune response.
- Strict broad-spectrum sun protection is essential (SPF 50+, PA++++, covering UVA/UVB/HEV).
- Mesotherapy to Restore the Dermis and Basement Membrane
- Micro-injections (mesotherapy) of a blend of 5% tranexamic acid, glutathione, polynucleotides (PDRN), and non-cross-linked hyaluronic acid.
- Goal: restore the integrity of the basement membrane, prevent new pigment from dropping into the dermis, and help calm dermal micro-inflammation.
- Low-Fluence 1064 nm Picosecond Laser to Clear Melanophages
- 1064 nm picosecond laser in low-fluence toning mode (7–9 mm spot size, 0.6–0.9 J/cm², 5–10 Hz).
- The photomechanical effect shatters pigment-laden melanophages in the upper dermis into tiny fragments that the lymphatic system can clear naturally, with minimal heat buildup to limit rebound hyperpigmentation.
- Course: 6–10 sessions, spaced 3–4 weeks apart.
